We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
90 hedge funds and large institutions have $291M invested in Oric Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 28 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
78% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 9
8% more funds holding
Funds holding: 83 → 90 (+7)
4% less repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 28
12.87% less ownership
Funds ownership: 100.99% → 88.12% (-13%)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
18% less capital invested
Capital invested by funds: $353M → $291M (-$62.7M)
24% less call options, than puts
Call options by funds: $216K | Put options by funds: $285K
Holders
90
Holders Change
+7
Holders Change %
+8.43%
% of All Funds
1.43%
Holding in Top 10
6
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-14.29%
% of All Funds
0.1%
New
16
Increased
27
Reduced
28
Closed
9
Calls
$216K
Puts
$285K
Net Calls
-$69K
Net Calls Change
+$630K
Top Buyers
| 1 |
BlackRock
New York
|
+$9.48M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$6.49M |
| 3 |
VC
Vivo Capital
Palo Alto,
California
|
+$6.37M |
| 4 |
Franklin Resources
San Mateo,
California
|
+$6M |
| 5 |
Alkeon Capital Management
New York
|
+$4.1M |
Top Sellers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.92M |
| 2 |
SCM
Suvretta Capital Management
New York
|
-$3.83M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$2.68M |
| 4 |
O
OrbiMed
New York
|
-$2.25M |
| 5 |
PM
Prosight Management
Dallas,
Texas
|
-$1.49M |
